IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients

doi:10.3748/wjg.v17.i31.3636

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 31

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3365)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

343

HTML

2801

Figures (1-1)

221

Sum=3365

Aug 21, 2011 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (35)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 21, 2011; 17(31): 3636-3639
Published online Aug 21, 2011. doi: 10.3748/wjg.v17.i31.3636

Full Size Figure Download Figure

Figure 1 Distribution of IL28B single nucleotide polymorphisms by response to combined therapy with pegylated interferon-α plus oral treatment with ribavirin, in Chilean patients with chronic hepatitis C (genotype 1). A: rs12979860 genotype; B: rs12980275 genotype; C: rs8099917 genotype. SVR: Sustained virological response (n = 50); NR: Null responders (n = 49).

Citation: Venegas M, Villanueva RA, González K, Brahm J. IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients. World J Gastroenterol 2011; 17(31): 3636-3639
URL: https://www.wjgnet.com/1007-9327/full/v17/i31/3636.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i31.3636